MR
MRAI.US Marpai Inc
- Market cap
- USD 51.5M
- P/E
- -
- P/B
- 1.49x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MRAI.US undervalued?
Graham numberThe Graham number of Marpai Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Marpai Inc fundamental analysis
No fundamental analysis for Marpai Inc yet.
Marpai Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Marpai Inc
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai…
Full company profileMarpai Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Marpai Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | 3.53M | 14.2M | 24.3M | 37.2M | 28.2M | 18.1M | 17.2M |
| Gross Profit | -71.5K | -152K | 3.94M | 7.21M | 12.9M | 9.11M | 4.78M | 4.40M |
| Operating Income | -1.59M | -3.37M | -15.9M | -26.7M | -26.4M | -22.1M | -13.6M | -11.8M |
| EBITDA | -1.50M | -3.19M | -13.6M | -22.3M | -22.1M | -23.7M | -13.1M | -11.7M |
| Net Income | -1.67M | -4.41M | -16.0M | -26.5M | -28.8M | -22.1M | -16.6M | -15.5M |
| EPS | -0.33 | -0.88 | -3.15 | -5.23 | -4.14 | -1.92 | -0.95 | -0.60 |
| Balance Sheet | ||||||||
| Total Assets | 4.24M | 6.53M | 44.2M | 50.0M | 31.7M | 12.9M | 10.9M | 9.47M |
| Total Liabilities | 5.11M | 10.0M | 14.5M | 43.8M | 45.1M | 40.6M | 43.5M | 48.4M |
| Shareholders' Equity | -873K | -3.50M | 29.7M | 6.13M | -13.4M | -27.7M | -32.6M | -38.9M |
| Cash & Short-term Investments | 187K | 1.75M | 19.2M | 13.8M | 1.15M | 764K | 133K | 138K |
| Total Debt | 5.00M | 9.34M | 1.30T | 6.08M | 4.20M | 1.04M | 9.62M | 662K |
| Cash Flow | ||||||||
| Operating Cash Flow | -876K | -1.95M | -10.8M | -35.2M | -15.7M | -15.2M | -7.45M | -9.15M |
| Capital Expenditure | 378K | 600K | 1.74M | 966K | 966K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -1.25M | -2.55M | -12.5M | -36.2M | -15.7M | -15.2M | -7.45M | -9.15M |
| Ratios | ||||||||
| ROE | - | - | -53.8% | -431.5% | - | - | - | - |
| ROA | -39.5% | -67.6% | -36.2% | -53.0% | -90.8% | -171.5% | -151.9% | -164.1% |
| Net Profit Margin | - | -125.0% | -112.4% | -108.7% | -77.4% | -78.4% | -91.5% | -90.2% |
| Debt to Equity | - | - | 43,819.38x | 0.99x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Marpai Inc dividends
Marpai Inc has not paid dividends in the last 7 fiscal years.
Last stock split: 1:4 on Jun 29, 2023.
Who owns Marpai Inc
- Insiders 53.91%
- Institutions 3.83%
- Public & others 42.26%
- Shares outstanding 26.8M
- Free float 14.4M
Top funds holding MRAI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| SSgA U.S. Extended Market Index Class I | 700.00 | 0.01% | 0.00% | Dec 2023 |
Top institutions holding MRAI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| FNY Investment Advisers, LLC | 0.00 | 0.00% | -100.00% | Mar 2025 |
Marpai Inc company profile
- Company name
- Marpai Inc
- Ticker
- MRAI.US
- Exchange
- USA Stocks
- Listed since
- Oct 27, 2021
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 107
- Fiscal year end
- December
- Address
- 615 Channelside Drive, Tampa, FL, United States, 33602
- Phone
- 855 389 7330
- Website
- marpaihealth.com
About Marpai Inc
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
Marpai Inc management
4- Mr. Damien Francis LamendolaPresident, CEO & Director · born 1956
- Mr. Steve JohnsonCFO & Company Secretary · born 1971
- Mr. Yaron I. EitanCo-Founder & Independent Chairman of the Board · born 1956
- Ms. Mimi DavisPresident of MarpaiRx